TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,060,114 | -59.2% | 123,193 | -75.3% | 0.01% | -58.6% |
| Q1 2023 | $7,494,297 | +148.0% | 498,291 | +95.1% | 0.03% | +163.6% |
| Q4 2022 | $3,021,962 | +71.4% | 255,449 | -14.2% | 0.01% | +83.3% |
| Q3 2022 | $1,763,000 | +79.9% | 297,843 | +29.1% | 0.01% | +50.0% |
| Q2 2022 | $980,000 | -43.9% | 230,690 | +25.5% | 0.00% | -33.3% |
| Q1 2022 | $1,748,000 | +34.7% | 183,793 | +169.1% | 0.01% | +20.0% |
| Q4 2021 | $1,298,000 | +42.6% | 68,309 | +150.0% | 0.01% | +25.0% |
| Q3 2021 | $910,000 | +27.1% | 27,329 | +48.1% | 0.00% | +33.3% |
| Q2 2021 | $716,000 | – | 18,449 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |